Inactive Instrument

News InNexus Biotechnology, Inc. Other OTC

Equities

InNexus Biotechnology, Inc. cancelled the transaction announced on May 30, 2013.	13-05-30	CI
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces a Loan Facility of up to USD$2.5 Million	09-03-25	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies	09-03-06	PR
INNEXUS BIOTECHNOL : InNexus Completes Previously Announced Private Placement	09-01-27	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO Named Business Leader of the Year	08-11-17	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology Receives Patent Grants in Europe	08-10-30	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum	08-10-28	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at BioContactQuebec 2008	08-09-29	PR
INNEXUS BIOTECHNOL : St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership	08-09-19	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology Strengthens Patent Team With New Leadership	08-09-09	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC	08-09-08	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625	08-08-07	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds	08-08-06	PR
INNEXUS BIOTECHNOL : InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBC's Annual World Congress Conference in Boston on Aug 6th	08-07-31	PR

No results for this search